VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $3,224,000 | +56.9% | 186,346 | +0.0% | 0.00% | 0.0% |
| Q1 2017 | $2,055,000 | -25.1% | 186,265 | -1.4% | 0.00% | 0.0% |
| Q4 2016 | $2,743,000 | -43.1% | 188,932 | -3.7% | 0.00% | -50.0% |
| Q3 2016 | $4,818,000 | +49.6% | 196,244 | +22.7% | 0.00% | 0.0% |
| Q2 2016 | $3,221,000 | -41.4% | 159,936 | -23.5% | 0.00% | -33.3% |
| Q1 2016 | $5,496,000 | -98.8% | 208,965 | -95.3% | 0.00% | -98.7% |
| Q4 2015 | $447,890,000 | -40.6% | 4,406,208 | +4.2% | 0.24% | -43.4% |
| Q3 2015 | $754,581,000 | -99.9% | 4,230,186 | -1.9% | 0.42% | -13.3% |
| Q2 2015 | $958,048,978,000 | -0.6% | 4,312,622 | -11.2% | 0.49% | -0.2% |
| Q1 2015 | $964,208,735,000 | +22.0% | 4,854,540 | -12.1% | 0.49% | +21.4% |
| Q4 2014 | $790,485,401,000 | +105777.9% | 5,523,621 | -2.9% | 0.40% | +1.8% |
| Q3 2014 | $746,601,000 | +2.1% | 5,690,564 | -1.8% | 0.40% | +3.4% |
| Q2 2014 | $731,133,000 | -99.9% | 5,797,126 | -1.1% | 0.38% | -9.5% |
| Q1 2014 | $772,485,174,000 | +2.4% | 5,859,707 | -8.8% | 0.42% | -0.2% |
| Q4 2013 | $754,116,318,000 | +12.1% | 6,423,478 | -0.3% | 0.42% | +1.4% |
| Q3 2013 | $672,511,389,000 | +21.2% | 6,446,002 | -0.0% | 0.42% | +11.2% |
| Q2 2013 | $555,078,358,000 | – | 6,448,401 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,577,892 | $994,984,000 | 31.62% |
| Ruane, Cunniff & Goldfarb | 33,922,192 | $6,051,041,000 | 31.06% |
| LeVasseur Capital Partners LLC | 162,394 | $28,968,000 | 29.76% |
| FARLEY CAPITAL L.P. | 192,130 | $34,272,000 | 27.18% |
| Pershing Square Capital Management | 19,473,933 | $3,473,760,000 | 24.90% |
| Arrow Capital Management, LLC | 109,461 | $19,525,000 | 16.53% |
| Marble Arch Investments | 1,196,900 | $213,503,000 | 16.43% |
| Tesuji Partners | 1,368,040 | $244,414,000 | 15.82% |
| ValueAct Holdings | 14,994,261 | $2,674,676,000 | 15.55% |
| Hound Partners | 3,898,648 | $695,441,000 | 15.04% |